China NMPA Product Recall - Central venous catheter (trade name: Cytofi)

On March 12, 2019, B. Braun Medical (Shanghai) International Trading Co., Ltd. initiated a voluntary Class I recall of its Cytofel brand central venous catheters. This action, reported to the National Medical Products Administration (NMPA) and referencing the Shanghai Food and Drug Administration, stemmed from a critical manufacturing issue. A deviation in supplier parts led to a potential shift in the filler material used to seal the dead space between the catheter's lateral opening and its tip. This filler displacement creates a significant risk of catheter blockage or displacement, which could subsequently lead to infusion obstruction or a serious embolism in patients. Despite no injuries being reported to date, the company proactively conducted this high-risk recall to safeguard patient safety. The detailed models, specifications, and affected batches were outlined in a "Medical Device Recall Event Report Form," indicating the comprehensive nature of the required action under regulatory oversight. This incident highlights the importance of robust quality control and post-market surveillance in medical device manufacturing, ensuring product integrity and mitigating potential patient hazards.